Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Overview

• 1.1 Product Overview and Scope of Epidermal Growth Factor Receptor (EGFR) Inhibitor
• 1.2 Classification of Epidermal Growth Factor Receptor (EGFR) Inhibitor by Types
  • 1.2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Types in 2018
  • 1.2.3 Lung Cancer
  • 1.2.4 Colorectal Cancer
  • 1.2.5 Breast Cancer
  • 1.2.6 Others
• 1.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market by Application
  • 1.3.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Research Institutes and Research Institutions
  • 1.3.4 Clinic
  • 1.3.5 Other
• 1.4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market by Regions
  • 1.4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Epidermal Growth Factor Receptor (EGFR) Inhibitor Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Epidermal Growth Factor Receptor (EGFR) Inhibitor Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Epidermal Growth Factor Receptor (EGFR) Inhibitor Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Epidermal Growth Factor Receptor (EGFR) Inhibitor Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Epidermal Growth Factor Receptor (EGFR) Inhibitor Status and Prospect (2014-2024)
• 1.5 Global Market Size of Epidermal Growth Factor Receptor (EGFR) Inhibitor (2014-2024)

2 Company Profiles

• 2.1 Amgen Inc.
  • 2.1.1 Business Overview
  • 2.1.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 F. Hoffmann-La Roche Ltd.
  • 2.2.1 Business Overview
  • 2.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 AstraZeneca Plc
  • 2.3.1 Business Overview
  • 2.3.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Eli Lilly and Co.
  • 2.4.1 Business Overview
  • 2.4.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Novartis AG
  • 2.5.1 Business Overview
  • 2.5.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2017-2018)

3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Competition, by Players

• 3.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Players Market Share
  • 3.2.2 Top 10 Epidermal Growth Factor Receptor (EGFR) Inhibitor Players Market Share
• 3.3 Market Competition Trend

4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions

• 4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Market Share by Regions
• 4.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 4.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 4.5 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)

5 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Countries

• 5.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Countries (2014-2019)
• 5.2 USA Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 5.3 Canada Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)

6 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Countries

• 6.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Countries (2014-2019)
• 6.2 Germany Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 6.3 UK Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 6.4 France Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 6.5 Russia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 6.6 Italy Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Countries

• 7.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Countries (2014-2019)
• 7.2 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 7.3 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 7.4 Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 7.5 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)

8 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Countries

• 8.1 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Countries (2014-2019)
• 8.2 Brazil Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Epidermal Growth Factor Receptor (EGFR) Inhibitor by Countries

• 9.1 Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 9.3 UAE Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Growth Rate (2014-2019)

10 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Segment by Type

• 10.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Market Share by Type (2014-2019)
• 10.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Forecast by Type (2019-2024)
• 10.3 Lung Cancer Revenue Growth Rate (2014-2024)
• 10.4 Colorectal Cancer Revenue Growth Rate (2014-2024)
• 10.5 Breast Cancer Revenue Growth Rate (2014-2024)
• 10.6 Others Revenue Growth Rate (2014-2024)

11 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Segment by Application

• 11.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Application (2014-2019)
• 11.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Research Institutes and Research Institutions Revenue Growth (2014-2019)
• 11.5 Clinic Revenue Growth (2014-2019)
• 11.6 Other Revenue Growth (2014-2019)

12 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast (2019-2024)

• 12.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast (2019-2024)
• 12.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Forecast by Regions (2019-2024)
• 12.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Forecast (2019-2024)
• 12.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Forecast (2019-2024)
• 12.6 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology